Avalon globocare jointly files us and international patent application for breakthrough s-layer coated emulsome technology (slet) for next-generation drug delivery and cellular immunotherapy

Freehold, n.j., oct. 14, 2021 (globe newswire) -- avalon globocare corp. (nasdaq: avco) (avalon or the company), a clinical-stage global developer of cell-based technologies and therapeutics, today announced it has successfully co-developed a novel platform of s-layer coated emulsome technology (slet) for next-generation drug delivery and cellular immunotherapy, together with professor uwe sleytr and the university of natural resources and life sciences (boku) in vienna, austria.
AVCO Ratings Summary
AVCO Quant Ranking